Scientific work

Uzm. Dr. Naciye Demirel

29 publications. The source of the information is stated next to each publication.

Back to profile

  1. Primary Versus Secondary Warm Autoimmune Hemolytic Anemia: Clinical, Laboratory, and Treatment Outcomes in A 20-Year Retrospective Study

    European Archives of Medical Research, 2026

    DOI 10.14744/eamr.2025.68926 Open-access full textSource: OpenAlex

  2. Comparison of different response evaluation criteria in interim PET/CT for diffuse large B-cell lymphoma: is Δtotal metabolic tumor volume a worthwhile measure?

    Nuclear Medicine Communications, 2025

    DOI 10.1097/mnm.0000000000002047 PMID 40910350 Source: ORCID

  3. The assessment of health-related quality of life in patients with polycythemia vera

    Medicine, 2024

    DOI 10.1097/md.0000000000038814 PMID 39058813 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  4. Eş Zamanlı Multipl Miyelom ve Polisitemiya Vera Tanısı Konulan Nadir Bir Olgu

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2870.c11277 Source: OpenAlex

  5. Charlson Comorbidity Index (CCI) in Diffuse Large B-cell Lymphoma: A New Approach in a Multicenter Study

    Indian Journal of Hematology and Blood Transfusion, 2023

    DOI 10.1007/s12288-022-01567-5 PMID 36186233 1 citation (Europe PMC) Open-access full textSource: ORCID

  6. The Obesity Controversy: Does It Impact Treatment Response in Diffuse Large B-Cell Lymphoma?

    International Journal of Hematology-Oncology and Stem Cell Research, 2023

    DOI 10.18502/ijhoscr.v17i2.12643 PMID 37637766 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  7. Factors associated with quality of life in caregivers of patients with multiple myeloma

    Journal of Surgery and Medicine, 2023

    DOI 10.28982/josam.8002 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  8. The Frequency of Transfusion Reactions in Acute Period: Single Center Study

    Turkiye Klinikleri Journal of Internal Medicine, 2022

    DOI 10.5336/intermed.2022-92571 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  9. Survival in patients with multiple myeloma: evaluation of possible associations with bone marrow fibrosis and investigation of factors independently associated with survival

    Bulletin of the National Research Centre/Bulletin of the National Research Center, 2022

    DOI 10.1186/s42269-022-00926-6 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. Examination of the need for treatment and the variables affecting survival in patients with chronic lymphocytic leukemia without indication for treatment at admission

    Annals of Medical Research, 2022

    DOI 10.5455/annalsmedres.2021.06.455 Open-access full textSource: OpenAlex

  11. COVID-19 ve Kanser

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.668 Source: ORCID

  12. Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul

    Indian Journal of Hematology and Blood Transfusion, 2021

    DOI 10.1007/s12288-021-01462-5 PMID 35496971 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  13. Diffuse large B-cell lymphoma that develops after adalimumab using adalimumab in a patient with psoriasis

    TURKDERM, 2021

    DOI 10.4274/turkderm.galenos.2020.34356 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  14. Treatment Outcomes in Hairy Cell Leukemia: Data of Patients in a Tertiary Referral Hospital in Turkey for Over 20 Years

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2021

    DOI 10.4274/bmj.galenos.2021.85047 Open-access full textSource: OpenAlex

  15. An Unconventional Presentation of Multiple Myeloma: Bazex Syndrome

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2020

    DOI 10.4274/tjh.galenos.2020.2020.0308 PMID 32830932 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  16. How Does 2016 WHO Criteria for Polycythemia Vera Contribute to Our Daily Practice? A Single-Center Study from Turkey

    International Journal of Hematology-Oncology and Stem Cell Research, 2020

    DOI 10.18502/ijhoscr.v14i4.4478 PMID 33603984 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  17. Chanarin-Dorfman syndrome

    The Turkish Journal of Gastroenterology, 2018

    DOI 10.5152/tjg.2018.18014 PMID 30457558 18 citations (OpenAlex) Open-access full textSource: OpenAlex

  18. Could neutrophil CD64 expression be used as a diagnostic parameter of bacteremia in patients with febrile neutropenia?,Nötrofil CD64 Ekspresyonu Febril Nötropenik Hastaların Bakteriyemisinde Tanı Kriteri Olarak Kullanılabilir mi?

    Turkish Journal of Hematology, 2017

    DOI 10.4274/tjh.2016.0123 PMID 27348760 4 citations (Europe PMC) Open-access full textSource: ORCID

  19. Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

    Clinical Lymphoma Myeloma and Leukemia, 2017

    DOI 10.1016/j.clml.2017.07.255 PMID 28847475 15 citations (Europe PMC) Source: ORCID

  20. Novel Antifungal Drugs Against Fungal Pathogens: Do They Provide Promising Results for Treatment?

    Indian Journal of Hematology and Blood Transfusion, 2015

    DOI 10.1007/s12288-014-0370-8 PMID 25825558 2 citations (Europe PMC) Open-access full textSource: ORCID

  21. Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report

    Indian Journal of Hematology and Blood Transfusion, 2015

    DOI 10.1007/s12288-014-0402-4 PMID 25548445 4 citations (Europe PMC) Open-access full textSource: ORCID

  22. Bloodstream infections in patients with hematological malignancies: Which is more fatal – Cancer or resistant pathogens?

    Therapeutics and Clinical Risk Management, 2014

    DOI 10.2147/tcrm.s68450 PMID 25258539 38 citations (Europe PMC) Open-access full textSource: ORCID

  23. Primary or secondary antifungal prophylaxis in patients with hematological maligancies: Efficacy and damage

    Therapeutics and Clinical Risk Management, 2014

    DOI 10.2147/tcrm.s59683 PMID 24855365 3 citations (Europe PMC) Open-access full textSource: ORCID

  24. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies

    Journal of Infection in Developing Countries, 2014

    DOI 10.3855/jidc.4451 PMID 25212075 12 citations (Europe PMC) Open-access full textSource: ORCID

  25. First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

    British Journal of Haematology, 2014

    DOI 10.1111/bjh.12937 PMID 24815307 17 citations (Europe PMC) Open-access full textSource: ORCID

  26. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies

    African Health Sciences, 2013

    DOI 10.4314/ahs.v13i2.24 PMID 24235937 7 citations (Europe PMC) Open-access full textSource: ORCID

  27. When and which fungal pathogens should come to mind in patients with hematological malignancies

    2013

    1 citation (OpenAlex) Source: OpenAlex

  28. Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: One year experience

    African Health Sciences, 2012

    DOI 10.4314/ahs.v12i3.23 PMID 23382758 2 citations (Europe PMC) Open-access full textSource: ORCID

  29. Does Previous Interferon Use Have Negative Effect on Imatinib Response in Chronic Myeloid Leukemia (CML)? A Single Center Study.

    Blood, 2006

    DOI 10.1182/blood.v108.11.4821.4821 Source: OpenAlex